Azienda Ospedaliera, Ospedale San Carlo Borromeo

Milan 20153

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Breast Cancer, Receptors, Fibroblast Growth Factor, Urothelial Cancer

Studies at this site

• A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations — Completed
• A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer — Completed